Most of these combinations are manageable, plenty of people are on both, and weight gain from psychiatric medication is one of the commoner reasons people seek this treatment in the first place.<\/p>\n
There are a few specifics that need attention, and one that needs it more than the others.<\/p>\n
If you take a medication whose blood level is monitored, that changes the picture, and lithium is the clearest example.<\/p>\n
Lithium has a narrow range between an effective level and a toxic one, and its level rises when you become dehydrated. These medications can dehydrate you through their gastrointestinal effects. The prescribing information for them carries a warning about acute kidney injury due to volume depletion, with the majority of reported cases occurring in people who became dehydrated through nausea, vomiting or diarrhea.<\/p>\n
Put those two facts together and the implication is obvious: a bad week of vomiting on a GLP-1 is not a neutral event if you take lithium.<\/p>\n
What to do:<\/strong> tell the clinician who prescribes your lithium before you start a GLP-1. Ask what monitoring they want, and ask specifically what you should do if you have a period of vomiting or diarrhea. Get that answer in writing before you need it, not during.<\/p>\n Do not adjust your lithium yourself,<\/strong> in either direction, for any reason connected to this.<\/p>\n The same logic applies to anything else where levels are checked, including some anticonvulsant mood stabilizers. The general rule: if a blood test tells someone whether your dose is right, they need to know you are starting a medication that can dehydrate you.<\/p>\n Several antipsychotics cause substantial weight gain, and this is one of the settings people most want these medications for. That combination is being actively studied, and there are trials underway specifically in people taking clozapine and olanzapine. The results are not all in, so treat confident claims in either direction with caution.<\/p>\n Practical points that do apply now:<\/p>\n You should already be having metabolic monitoring<\/strong> if you take one of these. Weight, glucose and lipids. Adding a GLP-1 does not replace that and it gives the monitoring more to look at rather than less.<\/p>\n Tell your psychiatrist.<\/strong> Not as a formality. Weight change affects how some psychiatric medications are dosed, and your psychiatrist is the one watching your mental state alongside it.<\/p>\n Do not stop or reduce an antipsychotic because you have started a GLP-1.<\/strong> This should not need saying and it does. Relapse risk is not worth a faster result on the scale.<\/p>\n This one is underappreciated and it is about stacking rather than interaction.<\/p>\n Stimulants suppress appetite. So does your GLP-1. Both at once can leave someone eating very little without ever deciding to, because neither the medication nor the hunger is prompting them.<\/p>\n If you take both, the thing to watch is not a drug interaction, it is your intake. The cluster to check for: persistent fatigue that sleep does not fix, feeling cold when others are comfortable, hair shedding, dizziness on standing, losing strength, weight coming off faster than intended.<\/p>\n Several together means you need to eat on a schedule rather than on appetite, and it is worth raising with both prescribers.<\/p>\n Consider this scenario: someone on a stimulant starts a GLP-1 and finds they simply do not eat between breakfast and evening. They are delighted for two months. By month four they are cold, foggy, and losing strength in the gym, and they have attributed all of it to the GLP-1 because that is the newer medication. Both prescribers know about the other drug on paper. Neither has asked what a typical day of eating looks like.<\/p>\n Your mental health can change during any period of significant physical change, and it is worth watching rather than assuming it will look after itself.<\/p>\n Some people feel considerably better. Some report feeling flat, or losing something that food used to do for them. Neither is a failure and both are worth mentioning.<\/p>\n On a related point worth being accurate about, because it is widely misreported. In January 2026 the FDA requested that the warning about suicidal ideation and behaviour be removed from the labelling of the three weight-management products that carried it: Saxenda, Wegovy and Zepbound. The basis was the agency’s own analysis of 91 placebo-controlled trials covering more than 100,000 patients, which found no increased risk. Those labels were updated the following month and no longer carry the warning. The diabetes-indicated products never carried it.<\/p>\n The warning being gone is not the same as the subject being closed. In the same communication, the FDA advised clinicians that anyone who discloses such thoughts should be referred to a mental health professional for evaluation. That advice sits with your clinicians rather than in the label. So the labelled warning is gone and the instruction to take it seriously is not.<\/p>\n If your mood changes noticeably, tell someone. This is a sensitive area, and if you are struggling, your prescriber or your mental health clinician is the right place to start rather than something to work through alone.<\/p>\n The person who prescribes your psychiatric medication and the person who prescribes your GLP-1 both need to know about the other. That sounds obvious and it fails routinely, particularly when the GLP-1 comes from a telehealth service that never speaks to your psychiatrist.<\/p>\n A pharmacist is genuinely useful here too, because they can see the whole list and they are the right person for questions about timing and absorption.<\/p>\n Worth asking:<\/p>\n Side effects peak after each step up. Stacking that onto a period when your mental health is already unsettled is avoidable.<\/p>\n If you are going through something, or a psychiatric medication change is happening, that is a reasonable moment to ask for a GLP-1 dose increase to be delayed. Our guide on when to increase your tirzepatide dose<\/a> covers how that timing works, and most providers will shift a step if asked.<\/p>\n Our guide on how tirzepatide and semaglutide side effects compare<\/a> covers the differences between products, which matters if gastrointestinal effects are the thing threatening your other medication. And if a pause ever becomes necessary, our guide on taking a break and restarting<\/a> covers what that involves.<\/p>\n Most combinations are workable. The one needing real attention is any medication with a monitored blood level, lithium above all, because dehydration raises levels and these medications can dehydrate you: get a written plan for sick days before you need it. Tell your psychiatrist, keep your metabolic monitoring, and never reduce a psychiatric medication because the GLP-1 is working. If you take a stimulant, watch your intake rather than watching for an interaction. And if your mood shifts, say so.<\/p>\nAntipsychotics<\/h2>\n
Stimulants for ADHD<\/h2>\n
Mood, and what to report<\/h2>\n
The general principle<\/h2>\n
\n
A note on timing dose increases<\/h2>\n
The short version<\/h2>\n